Nuheara: Receives ethics approval to begin clinical trials

Nuheara Receives ethics approval to begin clinical trials

  • Nuheara (NUH) has received ethics approval from the Australian Hearing Human Research Ethics Committee (AHHREC) to commence its medical device clinical trial
  • The company has been working to develop multi-functional, personalised, intelligent hearing devices that augment a person’s hearing
  • The company said this supports its planned expansion into clinically tested and regulatory approved medical devices
  • The company Co-founder, Managing Director and CEO Justin Miller said National Acoustics Laboratories has now commenced recruiting for company’s medical device clinical trial
  • Recruitment has already begun for the trial, which the company says supports its planned expansion into clinically tested and regulatory approved medical devices
Steve Sam
Steve Sam
Steve Sam is a financial reporter, analyst, and commentator with a strong focus on banking technology, digital payments, and the future of financial services.

You May Also Like

Keye Launches AI Co-Pilot for Private Equity Due Diligence

A game-changing tool to enhance efficiency in investment evaluations.Highlights: Keye introduces an AI-powered co-pilot for due diligence.Streamlines the...

Regulators Urged to Prioritize Gen AI Threats Over Quantum Computing Risks

Insights on the evolving regulatory landscape in fintech and AI.Highlights: Exchange Association emphasizes urgency on Gen AI regulatory...

Cryptocurrency Scam Losses Surge to $17 Billion in 2025, Fuelled by AI

Analysis reveals AI-driven schemes are escalating crypto fraud incidences.Highlights: Losses from cryptocurrency scams reached $17 billion in 2025.AI...

Alpaca Surges to Unicorn Status in Fintech Landscape

A landmark achievement showcasing fintech innovation and disruption.Highlights: Alpaca reaches a valuation exceeding $1 billion.The firm specializes in...